The efficacy and safety profiles of carfilzomib based therapy in real world practice for patients with relapsed or refractory multiple myeloma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dae Sik Kim | - |
dc.date.accessioned | 2021-08-27T15:01:58Z | - |
dc.date.available | 2021-08-27T15:01:58Z | - |
dc.date.created | 2021-04-22 | - |
dc.date.issued | 2019-09-14 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/10397 | - |
dc.publisher | International Myeloma Society | - |
dc.title | The efficacy and safety profiles of carfilzomib based therapy in real world practice for patients with relapsed or refractory multiple myeloma | - |
dc.title.alternative | The efficacy and safety profiles of carfilzomib based therapy in real world practice for patients with relapsed or refractory multiple myeloma | - |
dc.type | Conference | - |
dc.contributor.affiliatedAuthor | Dae Sik Kim | - |
dc.identifier.bibliographicCitation | 17th International Myeloma Workshop | - |
dc.relation.isPartOf | 17th International Myeloma Workshop | - |
dc.relation.isPartOf | IMW 2019 | - |
dc.citation.title | 17th International Myeloma Workshop | - |
dc.citation.conferencePlace | US | - |
dc.citation.conferencePlace | Boston, USA | - |
dc.citation.conferenceDate | 2019-09-12 | - |
dc.type.rims | CONF | - |
dc.description.journalClass | 1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.